Results 91 to 100 of about 35,561 (168)

The molecular management of classic myeloproliferative neoplasm

Journal of the Egyptian National Cancer Institute
Background Whole-genome sequencing has enabled the development of a wide range of analytical tools to search for abnormalities associated with tumors. As classic myeloproliferative neoplasms (MPNs) are associated with genomic alterations in hematopoietic
Charlène G. S. Soro, Sara Benchikh, Adil El Hamouchi, Imane Morjane, Rachid Saile, Halima Lebrazi, Sanaa Nassereddine   +6 more
doaj   +1 more source

The association of bladder myeloid sarcoma and unclassified myelodysplastic/myeloproliferative disease [PDF]

, 2009
Myeloid sarcoma of the urinary bladder is a rare disorder. We report a 71-year-old man with hematuria who had a diffuse myeloid sarcoma of the bladder.
Bircan Sönmez, Mehmet Sönmez, Rasin Özyavuz, Sevdagül Mungan, Ümit Çobanoğlu   +4 more
core  

Neutralize the neutrophils! Neutrophil β1 /β2 integrin activation contributes to JAK2-V617F–driven thrombosis [PDF]

, 2018
Barbui, De Stefano, Sands, Stephen T. Oh, Wolach   +4 more
core   +2 more sources

MESENCHYMAL STEM CELLS IN PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS: IDLE OBSERVERS OR PART OF THE DISEASE? [PDF]

, 2019
Accurso, V., Cordova, A., Di Piazza, F., Di Stefano, A. B., Lo Re, J., Mancuso, S., Russo, A., Santoro, M., Siragusa, S.   +8 more
core   +1 more source

Patient-reported outcomes data from REVEAL at the time of enrollment (baseline): A prospective observational study of patients with polycythemia vera in the United States [PDF]

, 2018
Boccia, Ralph V, Colucci, Philomena, Grunwald, Michael R, Mesa, Ruben, Oh, Stephen T, Paranagama, Dilan, Parasuraman, Shreekant, Stein, Brady L   +7 more
core   +2 more sources

Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis

Blood Neoplasia
Katie Erdos, Aya Alshareef, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah   +4 more
doaj   +1 more source

The microenvironment in myeloproliferative neoplasm

HemaSphere, 2018
Simón Méndez-Ferrer, Claudia Korn
doaj   +1 more source

Improvement of psoriasis with ruxolitinib in a patient with myeloproliferative neoplasm: a therapeutic observation. [PDF]

An Bras Dermatol
Gomide LV, Ribeiro AMQ.
europepmc   +1 more source

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms [PDF]

, 2018
Abboud, Camille N.
core   +1 more source

Myelodysplastic/Myeloproliferative Neoplasm in a Dog: A Case Report. [PDF]

Vet Med Sci
Cha S, Yu D, Bae H.
europepmc   +1 more source